The changing role of radiation in the post-TME ERA of rectal cancer

Lily L. Lai, Charles Thomas

Research output: Contribution to journalArticle

Abstract

Total mesorectal excision (TME) for rectal cancer is now considered standard in the surgical treatment of rectal cancer. The application of this technique has resulted in a pooled pelvic recurrence rate of approximately 7%. Preoperative and postoperative radiation further decreases the local regional recurrence (LRR) rate in patients with rectal cancer but the reduction in risk is counterbalanced by increased short and long term toxicity. Lower LRR rates have not uniformly translated into more favorable overall survival. In addition, advances in imaging have resulted in more accurate pretreatment staging and have improved the ability to stratify patients based on risk of recurrence. Given low pelvic recurrence rates after TME-based surgery alone, the risks and toxicities of pelvic radiation, and superior imaging to select high risk patients, radiation may not be requisite in the treatment of all rectal cancer patients. In this review, we discuss the current status of radiation and LRR rates in rectal cancer after definitive surgical resection with respect to specific subsites and stages of disease, examine the impact of imaging in the selection of patients for radiation, and raise the possibility that predictive biomarkers may help to identify patients who may not require pelvic radiation.

Original languageEnglish (US)
Pages (from-to)243-248
Number of pages6
JournalCurrent Cancer Therapy Reviews
Volume6
Issue number3
DOIs
StatePublished - 2010

Fingerprint

Rectal Neoplasms
Radiation
Recurrence
Aptitude
Risk Reduction Behavior
Patient Selection
Biomarkers
Survival
Therapeutics

Keywords

  • Chemoradiation
  • Local recurrence rates
  • Rectal cancer
  • Total mesorectal excision

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Molecular Medicine

Cite this

The changing role of radiation in the post-TME ERA of rectal cancer. / Lai, Lily L.; Thomas, Charles.

In: Current Cancer Therapy Reviews, Vol. 6, No. 3, 2010, p. 243-248.

Research output: Contribution to journalArticle

@article{d58466811ce7493c863d2539ef09a5fd,
title = "The changing role of radiation in the post-TME ERA of rectal cancer",
abstract = "Total mesorectal excision (TME) for rectal cancer is now considered standard in the surgical treatment of rectal cancer. The application of this technique has resulted in a pooled pelvic recurrence rate of approximately 7{\%}. Preoperative and postoperative radiation further decreases the local regional recurrence (LRR) rate in patients with rectal cancer but the reduction in risk is counterbalanced by increased short and long term toxicity. Lower LRR rates have not uniformly translated into more favorable overall survival. In addition, advances in imaging have resulted in more accurate pretreatment staging and have improved the ability to stratify patients based on risk of recurrence. Given low pelvic recurrence rates after TME-based surgery alone, the risks and toxicities of pelvic radiation, and superior imaging to select high risk patients, radiation may not be requisite in the treatment of all rectal cancer patients. In this review, we discuss the current status of radiation and LRR rates in rectal cancer after definitive surgical resection with respect to specific subsites and stages of disease, examine the impact of imaging in the selection of patients for radiation, and raise the possibility that predictive biomarkers may help to identify patients who may not require pelvic radiation.",
keywords = "Chemoradiation, Local recurrence rates, Rectal cancer, Total mesorectal excision",
author = "Lai, {Lily L.} and Charles Thomas",
year = "2010",
doi = "10.2174/157339410791698179",
language = "English (US)",
volume = "6",
pages = "243--248",
journal = "Current Cancer Therapy Reviews",
issn = "1573-3947",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - The changing role of radiation in the post-TME ERA of rectal cancer

AU - Lai, Lily L.

AU - Thomas, Charles

PY - 2010

Y1 - 2010

N2 - Total mesorectal excision (TME) for rectal cancer is now considered standard in the surgical treatment of rectal cancer. The application of this technique has resulted in a pooled pelvic recurrence rate of approximately 7%. Preoperative and postoperative radiation further decreases the local regional recurrence (LRR) rate in patients with rectal cancer but the reduction in risk is counterbalanced by increased short and long term toxicity. Lower LRR rates have not uniformly translated into more favorable overall survival. In addition, advances in imaging have resulted in more accurate pretreatment staging and have improved the ability to stratify patients based on risk of recurrence. Given low pelvic recurrence rates after TME-based surgery alone, the risks and toxicities of pelvic radiation, and superior imaging to select high risk patients, radiation may not be requisite in the treatment of all rectal cancer patients. In this review, we discuss the current status of radiation and LRR rates in rectal cancer after definitive surgical resection with respect to specific subsites and stages of disease, examine the impact of imaging in the selection of patients for radiation, and raise the possibility that predictive biomarkers may help to identify patients who may not require pelvic radiation.

AB - Total mesorectal excision (TME) for rectal cancer is now considered standard in the surgical treatment of rectal cancer. The application of this technique has resulted in a pooled pelvic recurrence rate of approximately 7%. Preoperative and postoperative radiation further decreases the local regional recurrence (LRR) rate in patients with rectal cancer but the reduction in risk is counterbalanced by increased short and long term toxicity. Lower LRR rates have not uniformly translated into more favorable overall survival. In addition, advances in imaging have resulted in more accurate pretreatment staging and have improved the ability to stratify patients based on risk of recurrence. Given low pelvic recurrence rates after TME-based surgery alone, the risks and toxicities of pelvic radiation, and superior imaging to select high risk patients, radiation may not be requisite in the treatment of all rectal cancer patients. In this review, we discuss the current status of radiation and LRR rates in rectal cancer after definitive surgical resection with respect to specific subsites and stages of disease, examine the impact of imaging in the selection of patients for radiation, and raise the possibility that predictive biomarkers may help to identify patients who may not require pelvic radiation.

KW - Chemoradiation

KW - Local recurrence rates

KW - Rectal cancer

KW - Total mesorectal excision

UR - http://www.scopus.com/inward/record.url?scp=77958052909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958052909&partnerID=8YFLogxK

U2 - 10.2174/157339410791698179

DO - 10.2174/157339410791698179

M3 - Article

AN - SCOPUS:77958052909

VL - 6

SP - 243

EP - 248

JO - Current Cancer Therapy Reviews

JF - Current Cancer Therapy Reviews

SN - 1573-3947

IS - 3

ER -